1. Organización Mundial de la Salud [Internet]. Centro de Prensa, 2017. Nota descriptiva, cáncer. 2017 [updated 12 de Septiembre de 2018; cited 2017 27 de Septiembre de 2018]; Available from: http://www.who.int/mediacentre/factsheets/fs297/es/
2. Huh J. Epidemiologic overview of malignant lymphoma. Korean J Hematol. 2012 Jun;47(2):92-104.
3. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J. Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann Oncol. 2000;11 Suppl 1:3-10.
4. Morton LM, Sampson JN, Cerhan JR, Turner JJ, Vajdic CM, Wang SS, et al. Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014 Aug;2014(48):1-14.
5. GLOBOCAN [Internet]. Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. 2012 [cited 2017 28 de Septiembre de 2017]; Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.